Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 13/20 | 0.56 |
| ▸ | CDK7 | P50613 | 11/20 | 0.56 |
| ▸ | CCNE1 | P24864 | 8/20 | 0.56 |
| ▸ | CDK9 | P50750 | 6/20 | 0.56 |
| ▸ | CDK1 | P06493 | 2/20 | 0.56 |
| ▸ | CCNH | P51946 | 10/20 | 0.40 |
| ▸ | MNAT1 | P51948 | 10/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.35 |
| ▸ | KHK | P50053 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15224433 | 0.96 | CDK7 (0.59) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224926 | 0.96 | CDK2 (0.58) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224845 | 0.96 | CDK2 (0.58) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224511 | 0.95 | CDK2 (0.56) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224714 | 0.95 | CDK2 (0.58) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224595 | 0.93 | CDK7 (0.59) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224924 | 0.93 | CDK2 (0.59) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224627 | 0.93 | CDK2 (0.58) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224713 | 0.92 | CDK2 (0.60) | CDK2CDK7CCNE1CDK9CDK1 | |
| SCHEMBL15224582 | 0.91 | CDK2 (0.58) | CDK2CDK7CCNE1CDK9CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9567345-B2 | Pharmaceutically active pyrazolo-triazine derivatives | LEAD DISCOVERY CENTER GMBH (DE) | 2017-02-14 | — | — | US | claimed |
| EP-2820020-B1 | PYRAZOLO-TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2016-04-06 | — | — | EP | claimed |
| EP-2820020-A1 | PYRAZOLO - TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN- DEPENDENT KINASE INHINITORS | Lead Discovery Center GmbH (DE) | 2015-01-07 | — | — | EP | claimed |
| WO-2013128028-A1 | PYRAZOLO - TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN- DEPENDENT KINASE INHINITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2013-09-06 | — | — | WO | claimed |
| EP-2634190-A1 | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors | Lead Discovery Center GmbH (DE) | 2013-09-04 | — | — | EP | claimed |
| US-9567345-B2 | Pharmaceutically active pyrazolo-triazine derivatives | LEAD DISCOVERY CENTER GMBH (DE) | 2017-02-14 | — | — | US | disclosed |
| EP-2820020-B1 | PYRAZOLO-TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2016-04-06 | — | — | EP | disclosed |
| EP-2820020-B1 | PYRAZOLO-TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2016-04-06 | — | — | EP | disclosed |
| WO-2013128028-A1 | PYRAZOLO - TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN- DEPENDENT KINASE INHINITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2013-09-06 | — | — | WO | disclosed |
| EP-2634190-A1 | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors | Lead Discovery Center GmbH (DE) | 2013-09-04 | — | — | EP | disclosed |
| EP-2634190-A1 | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors | Lead Discovery Center GmbH (DE) | 2013-09-04 | — | — | EP | disclosed |